A Study of Emactuzumab and Atezolizumab Administered in Combination in Participants With Advanced Solid Tumors

NCT02323191 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

221

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Cancers

Interventions

DRUG: Atezolizumab
DRUG: Emactuzumab

Sponsor

Hoffmann-La Roche